Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
PLoS One. 2013;8(1):e53918. doi: 10.1371/journal.pone.0053918. Epub 2013 Jan 10.
Cathepsin X has been reported to be a tumor promotion factor in various types of cancer; however, the molecular mechanisms linking its activity with malignant processes are not understood. Here we present profilin 1, a known tumor suppressor, as a target for cathepsin X carboxypeptidase activity in prostate cancer PC-3 cells. Profilin 1 co-localizes strongly with cathepsin X intracellularly in the perinuclear area as well as at the plasma membrane. Selective cleavage of C-terminal amino acids was demonstrated on a synthetic octapeptide representing the profilin C-terminal region, and on recombinant profilin 1. Further, intact profilin 1 binds its poly-L-proline ligand clathrin significantly better than it does the truncated one, as shown using cathepsin X specific inhibitor AMS-36 and immunoprecipitation of the profilin 1/clathrin complex. Moreover, the polymerization of actin, which depends also on the binding of poly-L-proline ligands to profilin 1, was promoted by AMS-36 treatment of cells and by siRNA cathepsin X silencing. Our results demonstrate that increased adhesion, migration and invasiveness of tumor cells depend on the inactivation of the tumor suppressive function of profilin 1 by cathepsin X. The latter is thus designated as a target for development of new antitumor strategies.
组织蛋白酶 X 已被报道为多种癌症中的肿瘤促进因子;然而,其活性与恶性进程相关的分子机制尚不清楚。在这里,我们将原肌球蛋白 1(一种已知的肿瘤抑制因子)鉴定为前列腺癌细胞系 PC-3 中组织蛋白酶 X 羧肽酶活性的靶标。原肌球蛋白 1 在核周区以及质膜内在组织蛋白酶 X 中强烈共定位。在代表原肌球蛋白 C 末端区域的合成八肽以及重组原肌球蛋白 1 上证明了 C 末端氨基酸的选择性切割。此外,完整的原肌球蛋白 1 与它的聚-L-脯氨酸配体网格蛋白的结合能力明显优于截断形式,如使用组织蛋白酶 X 特异性抑制剂 AMS-36 以及原肌球蛋白 1/网格蛋白复合物的免疫沉淀所证明的那样。此外,肌动蛋白的聚合也依赖于聚-L-脯氨酸配体与原肌球蛋白 1 的结合,细胞中 AMS-36 的处理以及 siRNA 组织蛋白酶 X 沉默均促进了肌动蛋白的聚合。我们的结果表明,肿瘤细胞的粘附、迁移和侵袭能力的增加依赖于组织蛋白酶 X 对原肌球蛋白 1 的肿瘤抑制功能的失活。因此,后者被指定为开发新的抗肿瘤策略的靶标。